Related Articles
MicroRNA-33b-5p is overexpressed and inhibits GLUT4 by targeting HMGA2 in polycystic ovarian syndrome: An in vivo and in vitro study
Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study
Long non‑coding RNA SNHG20 promotes ovarian cancer development by targeting microRNA‑338‑3p to regulate MCL1 expression
Effects of hypoxia‑inducible factor‑1α on endometrial receptivity of women with polycystic ovary syndrome
Differential expression of plasma‑derived exosomal miRNAs in polycystic ovary syndrome as a circulating biomarker